Cargando…
Salivary Gland Carcinoma: Novel Targets to Overcome Treatment Resistance in Advanced Disease
Salivary gland carcinomas (SGC) account for less than 5% of head and neck malignant neoplasms, further subcategorized in over 20 histological subtypes. For the most part, treatment for advanced disease is guided by morphology. SGC in general respond poorly to standard chemotherapy, with short durabi...
Autores principales: | Di Villeneuve, Larissa, Souza, Ive Lima, Tolentino, Fernanda Davila Sampaio, Ferrarotto, Renata, Schvartsman, Gustavo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649804/ https://www.ncbi.nlm.nih.gov/pubmed/33194707 http://dx.doi.org/10.3389/fonc.2020.580141 |
Ejemplares similares
-
Corrigendum: Salivary Gland Carcinoma: Novel Targets to Overcome Treatment Resistance in Advanced Disease
por: Di Villeneuve, Larissa, et al.
Publicado: (2021) -
Current management and future challenges in salivary glands cancer
por: Locati, Laura D., et al.
Publicado: (2023) -
Salivary glands adenoid cystic carcinoma: a molecular profile update and potential implications
por: da Silva, Fernanda Jardim, et al.
Publicado: (2023) -
Metastatic Myoepithelial Carcinoma Ex Pleomorphic Adenoma of the Sublingual Salivary Gland
por: Ferreira, Ângela T, et al.
Publicado: (2023) -
Clear Cell Carcinoma of Minor Salivary Glands: The Nasopharynx, an Uncommon Site of Origin
por: Arifi, Samia, et al.
Publicado: (2022)